阿达格拉西布 Adagrasib (Everest)
阿达格拉西布是一种FDA批准的KRAS G12C靶向药物，用于治疗晚期非小细胞肺癌。
- The description claims that Adagrasib is effective for patients who are resistant to Sotorasib.
Specifications
- 通用名称
- Adagrasib, 阿达格拉西布
- 剂型
- 片剂
- 剂量
- 200mg
AI Readiness
Good foundation, but some important product data is still missing.
69%